Postjunctional α2C-adrenoceptor contractility in human saphenous vein

European Journal of Pharmacology

Volumn 413, Issue 2-3, 2001, Pages 263-269

  Rizzo, Charles A ^a   Ruck, Lori M ^a   Corboz, Michel R ^a   Umland, Shelby P ^a   Wan, Yuntao ^a   Shah, Himanshu ^a   Jakway, James ^a   Cheng, Lihong ^a   McCormick, Kevin ^a   Egan, Robert W ^a   Hey, John A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

2C adrenoceptor; Human saphenous vein

Indexed keywords

2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ETHYL 3,4,5 TRIMETHOXY ALPHA [3 [[2 (2 METHOXYPHENOXY)ETHYL]AMINO]PROPYL]BENZENEACETONITRILE FUMARATE; BRIMONIDINE; PHENYLEPHRINE; PRAZOSIN; TALIPEXOLE; YOHIMBINE;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BIOASSAY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SAPHENOUS VEIN; VENOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANIMALS; AZEPINES; CHO CELLS; CRICETINAE; DIOXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA-2; SAPHENOUS VEIN; VASOCONSTRICTION; YOHIMBINE;

EID: 0035895550     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00772-5     Document Type: Article

References (28)

1. Vascular α-adrenoceptors: From the gene to the human
2. 50) of an enzymatic reaction
3. Adrenergic mechanisms in the control of gastrointestinal motility: From basic science to clinical applications
4. The use of the human saphenous vein in pharmacology
5. An examination of 5-hydroxytryptamine receptors in human saphenous vein
6. Maintenance of functional activity of human pulmonary arteries after cryopreservation
7. 2C-Adrenoceptors mediate contractile responses to noradrenaline in the human saphenous vein
8. 10. Catecholamines, sympathetic drugs, and adrenergic receptor antagonists
9. 1A-adrenergic receptor (the gene for which is located on human chromosome 5)
10. 2-adrenoceptor-subtype function
11. Assessment of alpha-adrenergic receptor subtypes in isolated rat aortic segments
12. Alpha-adrenoceptors: A critical review
13. Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins
14. 1-adrenoceptors in vascular smooth muscle
15. The distribution and significance of CNS adrenoceptors examined with in situ hybridization
16. 2-adrenoceptor subtypes in dog and rat veins
17. 2C-adrenoceptors in human neuroblastoma SH-SY5Y cells
18. 2-adrenoceptor antagonist in the human saphenous vein in vitro
19. 2C-Adrenoceptor-modulated release of noradrenaline in human right atrium
20. 2-adrenoceptor mediating contractions of the human saphenous vein
21. 2-adrenergic receptor subtypes in nasal epithelium, duct, gland and vascular cells
22. The postjunctional α-adrenoceptors of the human saphenous vein
23. I. Pharmacologic methods for identification of receptors
24. 2C subtype mediate inhibition of norepinephrine release in human kidney cortex
25. 2-autoreceptors: Rat vena cava, rat atria, human kidney and guinea pig urethra
26. 3 receptors in human saphenous vein and guinea pig ileum
27. Differences in α-adrenergic responsiveness between human internal mammary arteries and saphenous veins